Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00151138 · ClinicalTrials.gov registry record · NA
Cognitive/Cerebrovascular Consequences of HTN Treatment
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00151138 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants.
The verdict
NCT00151138, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Randomized trial of two antihypertensive drugs of known efficacy to investigate whether one has more favorable effects on brain blood flow and cognitive function.
Interventions
- DRUG Atenolol (drug), Lisinopril (drug)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2002-09 |
| Est. Completion | 2007-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00151138
The ClinicalTrials.gov registry entry for NCT00151138 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atenolol (drug), Lisinopril (drug) is the first listed.
NCT00151138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00151138 about?
NCT00151138 is a clinical study titled "Cognitive/Cerebrovascular Consequences of HTN Treatment". Randomized trial of two antihypertensive drugs of known efficacy to investigate whether one has more favorable effects on brain blood flow and cognitive function.
What is the current status of trial NCT00151138?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2002-09. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00151138?
The interventions under investigation include: Atenolol (drug), Lisinopril (drug) (DRUG).
Who is sponsoring clinical trial NCT00151138?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.